will telemedicine mitigate financial toxicity for prostate cancer patients
Published 3 years ago • 2 plays • Length 4:12Download video MP4
Download video MP3
Similar videos
-
1:30
will telemedicine mitigate financial toxicity for cll patients?
-
1:44
will telemedicine mitigate financial toxicity for myeloma patients
-
1:45
what are the limitations of telemedicine for prostate cancer patients
-
5:56
how will telemedicine impact prostate cancer clinical trials
-
1:34
what are the benefits of telemedicine for prostate cancer patients
-
2:16
can prostate cancer patients rely on telemedicine without risk?
-
2:51
should prostate cancer patients and families keep using telemedicine?
-
2:17
what prostate cancer population will benefit most from telemedicine
-
2:01
dr leanne burnham’s top tips for your prostate cancer telemedicine visit
-
1:43
telemonitoring and how it benefits prostate cancer patients
-
5:20
what are potential telemedicine risks for myeloproliferative neoplasm patients?
-
1:31
what is personalized prostate cancer medicine?
-
3:32
how can prostate cancer patients and providers help ensure quality care
-
29:16
thriving with prostate cancer: what you should know about care and treatment
-
4:47
what are current prostate cancer treatment options?
-
6:00
when should prostate cancer patients consider a clinical trial?
-
3:15
what should prostate cancer patients know about clinical trials?
-
31:45
thriving with prostate cancer | tools for navigating care and treatment
-
3:49
what questions should prostate cancer patients ask about clinical trials?